New Insights into the Connection Between Histone Deacetylases, Cell Metabolism, and Cancer

被引:12
|
作者
Chiaradonna, Ferdinando [1 ,2 ]
Cirulli, Claudia [1 ,2 ]
Palorini, Roberta [1 ,2 ]
Votta, Giuseppina [1 ,2 ]
Alberghina, Lilia [1 ,2 ]
机构
[1] SYSBIO Ctr Syst Biol, Milan, Italy
[2] Univ Milano Bicocca, Dept Biotechnol & Biosci, I-20126 Milan, Italy
关键词
TRANSCRIPTION FACTOR YY1; DEPENDENT PROTEIN-KINASE; ACUTE MYELOID-LEUKEMIA; YIN YANG 1; C-MYC; TUMOR-SUPPRESSOR; LYSINE ACETYLATION; PYRUVATE-KINASE; SKELETAL-MUSCLE; GENE-EXPRESSION;
D O I
10.1089/ars.2014.5854
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Significance: Histone deacetylases (HDACs) activity and cell metabolism are considered important targets for cancer therapy, as both are deregulated and associated with the onset and maintenance of tumors. Recent Advances: Besides the classical function of HDACs as HDAC enzymes controlling the transcription, it is becoming increasingly evident that these proteins are involved in the regulation of several other cellular processes by their ability to deacetylate hundreds of proteins with different functions in both the cytoplasm and the nucleus. Importantly, recent high-throughput studies have identified as important target proteins several enzymes involved in different metabolic pathways. Conversely, it has been also shown that metabolic intermediates may control HDACs activity. Consequently, the acetylation/deacetylation of metabolic enzymes and the ability of metabolic intermediates to modulate HDACs may represent a cross-talk connecting cell metabolism, transcription, and other HDACs-controlled processes in physiological and pathological conditions. Critical Issues: Since metabolic alterations and HDACs deregulation are important cancer hallmarks, disclosing connections among them may improve our understanding on cancer mechanisms and reveal novel therapeutic protocols against this disease. Future Directions: High-throughput metabolic studies performed by using more sophisticated technologies applied to the available models of conditional deletion of HDACs in cell lines or in mice will fill the gap in the current understanding and open directions for future research. Antioxid. Redox Signal. 23, 30-50.
引用
收藏
页码:30 / 50
页数:21
相关论文
共 50 条
  • [41] The interplay between microRNAs and histone deacetylases in neurological diseases
    Bourassa, Megan W.
    Ratan, Rajiv R.
    NEUROCHEMISTRY INTERNATIONAL, 2014, 77 : 33 - 39
  • [42] Histone deacetylases as new therapy targets for platinum-resistant epithelial ovarian cancer
    Pchejetski, Dmitri
    Alfraidi, Albandri
    Sacco, Keith
    Alshaker, Heba
    Muhammad, Aun
    Monzon, Leonardo
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2016, 142 (08) : 1659 - 1671
  • [43] Histone deacetylases modulate resistance to the therapy in lung cancer
    Contreras-Sanzon, Estefania
    Prado-Garcia, Heriberto
    Romero-Garcia, Susana
    Nunez-Corona, David
    Ortiz-Quintero, Blanca
    Luna-Rivero, Cesar
    Martinez-Cruz, Victor
    Carlos-Reyes, Angeles
    FRONTIERS IN GENETICS, 2022, 13
  • [44] Targeting histone deacetylases: development of vorinostat for the treatment of cancer
    Richon, Victoria M.
    EPIGENOMICS, 2010, 2 (03) : 457 - 465
  • [45] Role of Histone Deacetylases and Their Inhibitors in Cancer Biology and Treatment
    Beumer, Jan H.
    Tawbi, Hussein
    CURRENT CLINICAL PHARMACOLOGY, 2010, 5 (03): : 196 - 208
  • [46] Histone deacetylases and the immunological network: implications in cancer and inflammation
    Villagra, A.
    Sotomayor, E. M.
    Seto, E.
    ONCOGENE, 2010, 29 (02) : 157 - 173
  • [47] Histone Deacetylases in the Process of Halisarca dujardini Cell Reaggregation
    O. I. Kravchuk
    A. V. Burakov
    N. G. Gornostaev
    K. V. Mikhailov
    K. I. Adameyko
    A. D. Finoshin
    A. A. Georgiev
    V. S. Mikhailov
    Y. E. Yeryukova
    G. A. Rubinovsky
    D. V. Zayts
    G. R. Gazizova
    O. A. Gusev
    E. I. Shagimardanova
    Y. V. Lyupina
    Russian Journal of Developmental Biology, 2021, 52 : 319 - 333
  • [48] Role of Natural Products in Modulating Histone Deacetylases in Cancer
    Merarchi, Myriam
    Sethi, Gautam
    Shanmugam, Muthu K.
    Fan, Lu
    Arfuso, Frank
    Ahn, Kwang Seok
    MOLECULES, 2019, 24 (06)
  • [49] The Roles of Histone Deacetylases in the Regulation of Ovarian Cancer Metastasis
    Xu, Long
    Yan, Xiaoyu
    Wang, Jian
    Zhao, Yuanxin
    Liu, Qingqing
    Fu, Jiaying
    Shi, Xinyi
    Su, Jing
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (20)
  • [50] Histone acetyltransferases and deacetylases in the control of cell proliferation and differentiation
    Lehrmann, H
    Pritchard, LL
    Harel-Bellan, A
    ADVANCES IN CANCER RESEARCH, VOL 86, 2002, 86 : 41 - 65